[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI882912A0 - Laekemedelspreparat med finfoerdelade ebselen-kristaller. - Google Patents

Laekemedelspreparat med finfoerdelade ebselen-kristaller.

Info

Publication number
FI882912A0
FI882912A0 FI882912A FI882912A FI882912A0 FI 882912 A0 FI882912 A0 FI 882912A0 FI 882912 A FI882912 A FI 882912A FI 882912 A FI882912 A FI 882912A FI 882912 A0 FI882912 A0 FI 882912A0
Authority
FI
Finland
Prior art keywords
ebselen
laekemedelspreparat
kristaller
finfoerdelade
med
Prior art date
Application number
FI882912A
Other languages
English (en)
Other versions
FI88256C (fi
FI882912A (fi
FI88256B (fi
Inventor
Axel Roemer
Juergen Seidel
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of FI882912A0 publication Critical patent/FI882912A0/fi
Publication of FI882912A publication Critical patent/FI882912A/fi
Application granted granted Critical
Publication of FI88256B publication Critical patent/FI88256B/fi
Publication of FI88256C publication Critical patent/FI88256C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D293/00Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D293/12Selenazoles; Hydrogenated selenazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI882912A 1987-06-20 1988-06-17 Foerfarande foer framstaellning av fasta laekemedelspreparat av 2-fenyl-1,2-bensisoselenazol-3(2h)-on (ebselen) FI88256C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873720493 DE3720493A1 (de) 1987-06-20 1987-06-20 Arzneizubereitungen mit mikronisierten ebselen-kristallen
DE3720493 1987-06-20

Publications (4)

Publication Number Publication Date
FI882912A0 true FI882912A0 (fi) 1988-06-17
FI882912A FI882912A (fi) 1988-12-21
FI88256B FI88256B (fi) 1993-01-15
FI88256C FI88256C (fi) 1993-04-26

Family

ID=6330016

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882912A FI88256C (fi) 1987-06-20 1988-06-17 Foerfarande foer framstaellning av fasta laekemedelspreparat av 2-fenyl-1,2-bensisoselenazol-3(2h)-on (ebselen)

Country Status (25)

Country Link
US (1) US5021242A (fi)
EP (1) EP0296389B1 (fi)
JP (1) JPH0713016B2 (fi)
KR (1) KR970005322B1 (fi)
AT (1) ATE69165T1 (fi)
AU (1) AU603454B2 (fi)
CA (1) CA1310906C (fi)
DD (1) DD271056A5 (fi)
DE (2) DE3720493A1 (fi)
DK (1) DK173628B1 (fi)
ES (1) ES2041736T3 (fi)
FI (1) FI88256C (fi)
GE (1) GEP19960342B (fi)
GR (1) GR3003084T3 (fi)
HU (1) HU200096B (fi)
IE (1) IE63512B1 (fi)
LT (1) LT3669B (fi)
LV (1) LV10381B (fi)
MX (1) MX169170B (fi)
NO (1) NO175133C (fi)
NZ (1) NZ225066A (fi)
PT (1) PT87767B (fi)
RU (1) RU1834657C (fi)
UA (1) UA12648A (fi)
ZA (1) ZA884025B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5368864A (en) * 1988-11-25 1994-11-29 Henning Berlin Gmbh Chemie- Und Pharmawerk Formulation of oxypurinol and/or its alkali and alkaline earth salts
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
JP2553434B2 (ja) * 1992-04-28 1996-11-13 第一製薬株式会社 粒状製剤
DE69328128T2 (de) * 1993-10-27 2000-08-24 Daiichi Pharmaceutical Co., Ltd. Granuläre zubereitung
US5609883A (en) * 1994-09-16 1997-03-11 Advanced Technology Pharmaceuticals Corporation Compressed tablet transitory lubricant system
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
ES2181868T3 (es) * 1995-02-28 2003-03-01 Aventis Pharma Inc Composicion farmaceutica para compuestos de piperidinoalcanol.
CZ295461B6 (cs) * 1997-08-26 2005-08-17 Aventis Pharmaceuticals Inc. Farmaceutický prostředek ve formě dvouvrstvé tablety
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
WO2000058281A1 (fr) 1999-03-31 2000-10-05 Daiichi Pharmaceutical Co., Ltd. Substrats pour thioredoxine reductase
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
JP2006518754A (ja) * 2003-02-24 2006-08-17 マリンクロッド・インコーポレイテッド ベンズヒドリルチオアセトアミドの改良製法
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
US20080293777A1 (en) * 2007-05-23 2008-11-27 Erlanson Daniel A Weight Loss Treatment
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
TW201613888A (en) 2014-09-26 2016-04-16 Helsinn Healthcare Sa Crystalline forms of an NK-1 antagonist
WO2022167778A1 (en) * 2021-02-02 2022-08-11 Haiku Therapeutics Ltd Ebselen as adenosine receptor modulator
WO2023240092A1 (en) * 2022-06-06 2023-12-14 Sound Pharmaceuticals Inc. Ebselen containing oral dosage forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027073C2 (de) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
DE3407511A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolthione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3620674A1 (de) * 1986-06-20 1987-12-23 Nattermann A & Cie Salbe zur behandlung von hauterkrankungen

Also Published As

Publication number Publication date
ZA884025B (en) 1988-12-20
GR3003084T3 (en) 1993-02-17
HUT50037A (en) 1989-12-28
US5021242A (en) 1991-06-04
DE3720493A1 (de) 1989-01-26
HU200096B (en) 1990-04-28
DD271056A5 (de) 1989-08-23
NO882615D0 (no) 1988-06-14
EP0296389A1 (de) 1988-12-28
EP0296389B1 (de) 1991-11-06
DK173628B1 (da) 2001-05-07
LT3669B (en) 1996-01-25
KR890000084A (ko) 1989-03-11
NO175133B (no) 1994-05-30
AU603454B2 (en) 1990-11-15
MX169170B (es) 1993-06-23
JPH01100125A (ja) 1989-04-18
DK333388A (da) 1988-12-21
ATE69165T1 (de) 1991-11-15
FI88256C (fi) 1993-04-26
KR970005322B1 (ko) 1997-04-15
IE881628L (en) 1988-12-20
PT87767B (pt) 1992-10-30
ES2041736T3 (es) 1996-07-16
DE3866033D1 (de) 1991-12-12
NO175133C (no) 1994-09-07
DK333388D0 (da) 1988-06-17
NO882615L (no) 1988-12-21
LTIP903A (en) 1995-03-27
GEP19960342B (en) 1996-02-20
CA1310906C (en) 1992-12-01
FI882912A (fi) 1988-12-21
IE63512B1 (en) 1995-05-03
NZ225066A (en) 1990-07-26
FI88256B (fi) 1993-01-15
LV10381A (lv) 1995-02-20
UA12648A (uk) 1997-02-28
PT87767A (pt) 1989-05-31
RU1834657C (ru) 1993-08-15
AU1811688A (en) 1988-12-22
JPH0713016B2 (ja) 1995-02-15
LV10381B (en) 1995-06-20

Similar Documents

Publication Publication Date Title
FI882912A0 (fi) Laekemedelspreparat med finfoerdelade ebselen-kristaller.
IS1564B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
PT86819A (pt) Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same
IL76454A (en) Diarylacetylene derivatives,their preparation and pharmaceutical compositions containing them
SE8700499D0 (sv) Novel pharmacologically active compounds
NO853699L (no) Tetralinderivater, fremstilling og anvendelse derav.
NO884467D0 (no) Analogifremgangsmaate for fremstilling av aminomethyloxooxazolidinyl-ycloalkylbenzenderivater.
NO883506D0 (no) Fremgangsmaate for fremstilling av foretrede polyoksyalkylenderivater.
ATE90345T1 (de) Bis-naphthalimide, ihre herstellung und verwendung.
ES2032376T3 (es) Procedimiento para preparar 2-sustituidos-(amino-sustituidos)-n-arilalquil-3-(indol-3-il)propanimidas.
IS3284A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
DK324185A (da) 2-substituerede 1,3-propylidendiphosphonatderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf
SE8404065D0 (sv) Novel biologically active compounds
ES2012339B3 (es) Preparacion oral de ajo y procedimiento para su fabricacion
ATE21248T1 (de) Derivate von 1h,3h-pyrrolo(1,2-c)thiazol, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
PT87550A (pt) Process for the preparation of pyrimidine derivatives and of pharmaceutical compositions containing the same
DK243280A (da) 3,4,5-trihydroxypiperidinderivater deres fremstilling og anvendelse
SE8306225D0 (sv) 2-piperazinyl-quinazoline derivatives, their production and pharmaceutical compositions containing them
NZ220800A (en) Tetrahydrobenzothiazoles and pharmaceutical compositions
ATE12241T1 (de) Leukotrienaehnliche verbindungen, deren herstellung und verwendung in pharmazeutischen zusammensetzungen.
AU6740187A (en) Heterocyclic compounds, methods for the manufacture of the same and pharmaceutical compositions containing the same
IT7824580A0 (it) Composizione farmaceutica per il trattamento di stati di impotenza maschile e di stati psichici alterati.

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: A. NATTERMANN & CIE GMBH